Back to News
Market Impact: 0.25

C3.ai vs. CrowdStrike: Which Technology Stock Is a Better Buy in 2026?

Source: Nasdaq

Artificial IntelligenceCybersecurity & Data PrivacyCompany FundamentalsAnalyst InsightsCorporate EarningsTechnology & Innovation
C3.ai vs. CrowdStrike: Which Technology Stock Is a Better Buy in 2026?

CrowdStrike is favored over C3.ai for 2026 after delivering FY2026 revenue growth of 21.7% to approximately $4.8B and positive free cash flow of roughly $1.3B, despite a $162.5M net loss and a rich 44.7x price-to-sales valuation. C3.ai reported FY2026 revenue of about $250.3M, down 35.7% year over year, a $470.4M net loss, and negative free cash flow of $190.7M; management is restructuring sales after cutting roughly one-third of its workforce. The article views CrowdStrike's mission-critical cybersecurity platform and AI-driven security demand as a more dependable long-term investment, while flagging its post-outage legal risks and elevated valuation.

Analysis

The investable distinction is not simply cybersecurity versus enterprise AI; it is recurring mission-critical spend versus a discretionary implementation budget. CRWD can monetize AI adoption even when enterprises choose hyperscaler-native data and AI tools, while AI must compete against MSFT, AMZN and GOOG bundles that can be subsidized by cloud commitments. That makes AI's sales reset a potential source of further estimate cuts over the next 1-3 quarters, whereas CRWD's key debate is valuation durability rather than demand viability.

CRWD's premium multiple leaves little tolerance for a deceleration in net-new ARR, weaker module adoption, or incremental costs tied to customer remediation and litigation. The more relevant quality adjustment is stock-based-compensation dilution: cash-flow-based valuation screens overstate owner earnings unless operating leverage outruns dilution. Over 6-18 months, consolidation toward endpoint/cloud/identity platforms should pressure point vendors such as TENB and RPD more than it pressures CRWD, PANW or ZS.

Consensus is likely too one-sided on a CRWD-versus-AI pair. AI's equity value increasingly reflects a distressed-growth outcome, and a stabilization in bookings, a large federal/energy award, or partner-led deal conversion could create a sharp short-covering move despite poor fundamentals; its net-cash balance reduces near-term financing risk. Conversely, CRWD's installed-base advantage is real, but any evidence that customers are standardizing security through Microsoft bundles or demanding price concessions would have an outsized multiple impact from an elevated starting point.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.15

Ticker Sentiment

AI-0.90
AMZN0.05
BKR0.05
CRWD0.82
GOOG-0.12

Key Decisions for Investors

  • Prefer a 3-6 month long CRWD / short AI pair only after confirming AI's next bookings or remaining-performance-obligation update remains negative: size dollar-neutral, with a 15-20% target spread return. Cover the AI short if bookings stabilize for two consecutive quarters or a material government/energy contract materially lifts forward revenue visibility.
  • For less single-name incident risk, own PANW over CRWD for new cybersecurity exposure over 6-12 months. PANW offers platform-consolidation exposure at a less demanding valuation framework; reassess if PANW's next billings/RPO trend shows renewed firewall or SASE weakness.
  • Do not chase CRWD outright following positive retail commentary. Accumulate only on a 10-15% pullback or after the next earnings release confirms net-new ARR acceleration and that legal/remediation expense is not expanding; a missed ARR or margin guide could produce a 20%+ de-rating given the starting multiple.
  • Maintain AI as a watch-list turnaround rather than a fundamental long. A long becomes actionable only if quarterly revenue returns to growth while cash burn falls materially; absent both signals, the likely 1-3 quarter catalyst remains downward guidance revisions rather than recovery.

More News

From AllMind Research

Browse all research